Published in Oncology Business Week, October 24th, 2004
AustCancer has contracted the Frankfurt based securities broker dealer firm, Seydler AG Securities and Financial Services, to act as Market Maker and Designated Sponsor for the company's shares on Xetra.
The Xetra listing is part of AustCancer's strategy to broaden its international shareholder base. The company already has a Level 1 ADR program on NASDAQ (Code AUCJY) and plans to complete a small cap NASDAQ listing by the third quarter of the current...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.